Roughly 1 in 8 US adults have taken GLP-1 drugs like Wegovy, poll…
(Reuters) - About one in eight adults have taken a drug belonging to the GLP-1 class of…
(Reuters) - About one in eight adults have taken a drug belonging to the GLP-1 class of…
By Jonathan Stempel (Reuters) - A leading shareholder advisory firm recommended on…
By Leroy Leo (Reuters) -UnitedHealth Group said on Friday its Change Healthcare unit will…
By Jonathan Stempel (Reuters) - Warren Buffett on Saturday moved to reassure investors…
By Jonathan Stempel (Reuters) - Warren Buffett's Berkshire Hathaway on Saturday…
By Manya Saini (Reuters) -New York Community Bancorp shares rose 5% on Thursday after it…
By Tom Hals WILMINGTON, Delaware (Reuters) - An unusual, billion-dollar trial between…
By Jonathan Saul, Helen Reid and Corina Pons LONDON/MADRID (Reuters) -Exporters are…
By Phil Stewart and John Davison MANAMA/DUBAI (Reuters) - The United States on Tuesday…
By Anirban Sen (Reuters) -U.S. health insurer Cigna has ended its attempt to negotiate an…
Welcome, Login to your account.
Welcome, Create your new account
A password will be e-mailed to you.